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spearman correlation analysis, there was a signiﬁcant negative correlation
between BMI and serum T levels was found.
CONCLUSIONS This study has found that increased BMI has a nega-
tive effect on serum testosterone levels and related hypogonadism.
Sexual hormone levels changes might represent additional motiva-
tional factors for men in order to maintain a healthy life-style.
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inhibition on myocardial apoptosis induced by ischemia/reperfusion
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OBJECTIVES Ischemia/reperfusion (I/R) is a pathological process that
results in extensive cell death. However, ischemic tissue of the myocar-
dium is susceptible to be further injuried deriving from reperfusion.
Although the mechanism of I/R injury involves multiple cellular processes,
apoptosis is an important pathogenesis of myocardial I/R injury. soluble
receptor for advanced glycation end products (sRAGE), the N-terminal
extracellular domain of the receptor for advanced glycation end products
(RAGE), can be derived either from enzymatic cleavage of full-length cell-
surface receptor or endogenous secretion of splice variants of RAGE.
RAGE, expressed in many tissues, is a transmembrane protein member of
the immunoglobulin superfamily. Activation of RAGE induces a number of
cell processes, including inﬂammation, apoptosis, proliferation and auto-
phagy. sRAGE may counteract RAGE-mediated pathogenesis by acting as a
decoy. Previous studies have shown that sRAGE has a protective effect on
coronary artery disease. However, the therapeutic effects of sRAGE in
heart injury after I/R remain unclear. We hypothesized that sRAGE inhibits
apoptosis induced by I/R in cardiomyocytes in vivo.
METHODS C57BL/6J mice exposure to left anterior descending coro-
nary artery ligation were used as in vivo models. At the end of
reperfusion, cardiac function was evaluated with echocardiography,
the myocardial infarct size was determined by the Evans blue/2, 3, 5-
triphenyltetrazolium chloride (TTC) double staining, myocardial
apoptosis was detected by TUNEL staining and caspase-3 activity.
RESULTS Compared to sham group, I/R decreased the cardiac systolic
function in mice: lowered the Left ventricular anterior wall (LVAW)
[(0.800.07)mm vs (1.180.07)mm, P < 0.05], and Left ventricular pos-
terior wall (LVPW) [(0.800.02)mm vs (1.180.01)mm, P < 0.05],
increased Left ventricular inside diameter (LVID) [(3.170.15)mm vs
(2.130.18)mm, P < 0.05], and Left ventricular volume (LV vol)
[(40.334.67)ul vs (15.523.47)ml, P < 0.05], decreased left ventricular
ejection fractions (EF) [(30.93.2)% vs (72.42.1)%, P < 0.05], and left
ventricular fractional shortening (FS)[(15.12.0)% vs (40.71.6)%, P <
0.05]; increased the myocardial infarct area (I/R,36.3% 2.3% of AAR vs.
sham, 0% of AAR, P < 0.05), TUNEL-positive myocytes [(20.01.6)% vs
(1.00.2)%, P < 0.05], and caspase-3 activity [(2.640.4)% vs (1.000.2)%,
P < 0.05]. Compared to I/R group, sRAGE pre treatment signiﬁcantly
improved EF [(46.52.0)% vs (30.93.2)%, P< 0.05], and FS [ (23.01.1)%
vs (15.12.0)%, P< 0.05], lowered the myocardial infarct area (18.0%1.1%
of AAR vs 36.3% 2.3% of AAR), diminished TUNEL-positive myocytes
[(9.21.0)% vs (20.01.6)%, P< 0.05], and caspase-3 activity [(1.940.1)%
vs (2.640.4)%, P< 0.05]. There were rare TUNEL-positive nuclei both in
sham and shamþsRAGE group (P > 0.05). There were no differences in
LVAW, LVPW, LVID and LV vol between I/R and I/RþsRAGE groups.
CONCLUSIONS These results suggest that sRAGE protects against I/R
induced-myocardial injury via inhibiting apoptosis.
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OBJECTIVES To investigate the relation of birth weight to infancy
growth on body fat composition in childhood.
METHODS This cross-sectional study included 382 children aged 5 to 7
years old in Guangzhou. Birth weight and length was obtained from
medical records as recorded in the delivery room. Weight and length
during infancy (birth to 2 years old) were available from routinely collectedfrom the individual health book. Physical examination included body
weight, body height and body fat composition indexes (body mass index
(BMI), percentage of body fat (PBF), waist circumference (WC) to height
ratio (WtHR). BPF were assessed by bioelectric impedance analysis (BIA).
PBF of 120 children 5w6 years old were assessed by single-frequency
bioelectrical impedance (Tanita, model BC-571). PBFof 262 children 6w7
years old were assessed by multi-frequency bioelectrical impedance (Bio-
space, InBody 3.0). According to birth weight tertile from low to high the
children were divided into three groups: BW-I, BW-II, BW-III group. Then
according to change in weight SDS between birth and 2 years t he children
were divided into three groups: changers up (CU), non-changers (NC),
changers down (CD) group. Relation of birth weight to infancy growth on
body fat composition was analyzed. Statistical analysis was performed by
using analysis of variance, q test and c2 test. P values less than 0.05 were
considered statistically signiﬁcant.
RESULTS Change in weight SDS between birth and 2 years was higher in
BW-I group than in the BW-II group and BW-III group (P <0.05). Birth
weight of the CU group was lower than that of the NC group and the CD
group (P <0.05). Among the BW-Igroup, the proportion of subjects in the
BW-I-CU group (61.76%) was higher than that in the non-BW-I-CU group
(38.24%) (P <0.05). The body fat composition indexes (BMI, PBF and
WtHR) were higher in the BW-III group than in the BW-I group and BW-II
group (P <0.05). The body fat composition indexes were higher in the CU
group than in the NC group and the CD group (P <0.05). In the CU group,
the body fat composition indexes were higher in the BW-III-CU group than
in the BW-I-CU group and BW-II-CU group (P <0.05).
CONCLUSIONS Both lower birth weight individuals with more weight
change-up growth in infancy and higher birth weight individuals had
greater body fat composition in childhood. They were high-risk people
of obesity. There is a need to develop public health policies that adopt
preventive measures to prevent different birth weight individuals
from fat mass accumulation postnatal early. Optimal life style during
pregnancy and infancy is necessary to prevent from fat mass accu-
mulation and further to prevent adult metabolic syndrome.
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OBJECTIVES In order to provide practitioners with an approach to the
rational, safe, and effective use of antibiotics for the prevention of surgical-
site infections (SSIs), study was carried out in 3 cardiac surgeries.
METHODS Information regarding patient-related factors associated with
an increased risk of SSIs, use of antimicrobial agents for SSIs and devel-
opment of incision infection during 2012w2014 in our hospital was
collected and summarized in 3 cardiac surgeries, including permanent
pacemaker implantation (90 cases), percutaneous coronary intervention
(180 cases) and cardiac radiofrequency ablation (90 cases).
RESULTS After 3 years of effort of clinical pharmacists collaborating
with the medical team, the ratio of prophylactic use of antibiotics in 3
cardiac surgeries in our hospital decreased from 100% to 20% as a
whole; the preoperative-dose timing is within 60 minutes before sur-
gical incision; selection, dosing and duration of prophylaxis of antibi-
otics for SSIs were rational and in accord with the latest guidelines.
CONCLUSIONS Based on this study, antimicrobial prophylaxis may not
be routine for percutaneous coronary intervention and cardiac radio-
frequency ablation. However, antimicrobial prophylaxis is recommended
for permanent pacemaker implantation, and the course of antimicrobial
prophylaxis should be limited in 48h. First generation cephalosporins
have been shown to be effective for the prevention of SSIs in patients
without being colonized with methicillin resistant Staphylococcus aureus.
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OBJECTIVES The spontaneously hypertensive rat (SHR) is the most
widely used model of essential hypertension and is predisposed to left
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bances. Recently, a quantitative trait locus (QTL) inﬂuencing blood
pressure, left ventricular mass and heart interstitial ﬁbrosis was
genetically isolated within 788 kb on chromosome 8 segment of SHR-
PD5 congenic strain that contains only 7 genes, including mutant Plzf
(Promyelocytic leukemia zinc ﬁnger protein) gene.
METHODS To identify Plzf as a quantitative trait gene (QTG), we
targeted Plzf in the SHR using the TALEN technique and obtained
SHR line harboring mutant Plzf gene with a premature stop codon at
position of amino acid 58. The Plzfmutant allele is semi-lethal
since approximately 95% of newborn homozygous animals die peri-
natally due to a caudal regression syndrome. Heterozygous rats were
grossly normal and were used for metabolic and hemodynamic
analyses.
RESULTS SHR-Plzfþ/- versus SHR wild type controls exhibited reduced
body weight and relative weight of epididymal fat, lower serum tri-
glycerides and liver triglycerides, as well as lower serum cholesterol and
liver cholesterol. In addition, SHR-Plzfþ/- rats exhibited signiﬁcantly
increased sensitivity of adipose and muscle tissue to insulin action
when compared to wild type controls. The SHR-Plzfþ/- heterozygous
rats vs. wild type controls showed signiﬁcant amelioration of car-
diomyocyte hypertrophy and ﬁbrosis. Gene expression proﬁles revealed
differential expression of genes with the role in cell cycle.
CONCLUSIONS These results provide evidence for important role of
Plzf in regulation of metabolic and hemodynamic traits in the rat and
suggest cross-talk between cell cycle regulators, metabolism, cardiac
hypertrophy and ﬁbrosis.
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OBJECTIVES Digital medical treatment is a new medical model which
uses information technology through the entire medical process. In
this study, we combined clinical medicine and information technol-
ogy to create “Adult Common Diseases Computer Diagnostic System”
and evaluate its clinical diagnostic value on coronary artery disease,
gastroduodenal ulcers and hypertension portal.
METHODS First, we selected some symptoms and their relative
common diseases. Second, we edited diagnostic key points (cause,
exciting cause, clinical manifestation, past history, personal history
and family history) into choice questions according to textbooks,
guidelines and expertise, and stored them to the question database.
And we stored diagnostic results (preliminary diagnosis, sign of dis-
ease, auxiliary examination and clinical departments to visit) to the
answer database. Then we linked the two databases using metadata
base technology through special logic rules. After that, we evaluated
diagnostic value on coronary artery disease of the diagnostic system
(symptom: chest pain) in cardiovascular department and diagnostic
value on gastroduodenal ulcers as well as hypertension portal of the
diagnostic system (symptom: hematemesis) in digestive system
department.
RESULTS “Adult Common Diseases Computer Diagnostic System” con-
sists of four main interfaces. They are symptom selection interface (choose
one’s own symptoms), symptomatic question interface (answer ques-
tions), diagnostic results interface (review diagnostic results), and sign and
auxiliary examination interface (review sign and auxiliary examination).
1310 patients with chest pain in cardiovascular department were included.
Among the total, 1025 patients underwent coronary angiography (CAG).
Compared with results of CAG for diagnosis of coronary artery disease,
diagnostic value for system was a sensitivity of 85.1% and a speciﬁcity of
32.6%. Compared with clinical diagnosis, diagnostic value for system was
a sensitivity of 76.4% and a speciﬁcity of 46.3% for angina pectoris; and a
sensitivity of 58.1% and a speciﬁcity of 83.8% for myocardial infarction.
170 patients with hematemesis in digestive system department were
included, 127 among them underwent gastroscope. Compared with results
of gastroscope for diagnosis of gastroduodenal ulcer, diagnostic value for
system was a sensitivity of 50% and a speciﬁcity of 85.9%. Compared with
clinical diagnosis for portal hypertension, diagnostic value for system was
a sensitivity of 54.3% and a speciﬁcity of 90.8%.
CONCLUSIONS We succeed to create “Adult Common Diseases
Computer Diagnostic System”. In view of preliminary clinicalevaluation, the system had a good clinical diagnostic value for being
widely used.GW26-e0382
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OBJECTIVES Many undesirable effects may appear during interferon
alpha treatment for chronic hepatitis B. However, only a few cardio-
vascular adverse effects associated with interferon alpha have been
reported. This paper provides a rare case report regarding cardiac
toxicity of interferon alpha for chronic hepatitis B treatment.
METHODS After 4 months of pegylated interferon alpha-2a treatment,
a 38-year-old male patient with chronic viral hepatitis B developed
mild chest tightness and chest pain accompanied by nausea, vomit-
ing. Dynamic electrocardiogram showed paroxysmal tachycardia and
abnormal ST-T (T wave inversion).
RESULTS After withdrawal of interferon alpha, symptoms such as
chest tightness, chest pain and T wave inversion were gradually
relieved. The patient had no history of coronary heart disease before
medication, so myocardial ischemia due to interferon alpha-2a treat-
ment was considered.
CONCLUSIONS Although interferon-induced myocardial ischemia is
rare, it is still likely to develop into fatal danger, if not diagnosed and
treated timely. Prescribers should be alert to the possibility of this
severe adverse drug reaction associated with interferon use.GW26-e1591
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OBJECTIVES Hyperglycemia is a risk factor for cardiovascular
disease. However, the relationship between blood glucose variability
and cardiac structure and function remains unclear. The present
study aimed to explore the impact of glucose variability on cardiac
structure and function in patients with type 2 diabetes mellitus
(T2DM).
METHODS According to glucose variability, which was assessed by
mean amplitude of glycemic excursions (MAGE), 63 consecutive type
2 diabetic patients under glycemic control without any coronary
artery disease and hypertension were divided into two groups: sub-
jects with non-glucose ﬂuctuation (MAGE<3.9mmol/l, n¼31) and
subjects with glucose ﬂuctuation (MAGE3.9mmol/l, n¼32). Thirty
healthy controls (NC) were also enrolled. Myocardial structural and
functional changes were evaluated by echocardiography including
left ventricle end diastolic diameter (LVEDD), left ventricle end sys-
tolic diameter (LVESD), left ventricle end diastolic volume (LVEDV),
left ventricular end systolic volume (LVESV), interventricular septal
thickness (IVST), left ventricular posterior wall thickness (LVPW),
ejection fraction (EF), Mitral E wave, Mitral A wave, E/A ratio, and
Tei index.
RESULTS LVESD, LVESV, IVST, LVPW and LVEF had no signiﬁcant dif-
ferences among all groups (p<0.05). However, when compared to non-
glucose ﬂuctuation subjects and NC group, LVEDD (51.124.92mm vs.
46.144.65mm vs. 45.323.37mm, p<0.05) and LVEDV (101.324.93mm
vs. 87.836.19mm vs. 90.515.34mm, p<0.05) were signiﬁcant higher in
patients with glucose ﬂuctuation, while E/A ratio was signiﬁcant lower
(0.770.38 vs. 0.980.46 vs. 1.280.23, p<0.05). Furthermore, the Tei
index was higher in T2DM patients than that in NC group (0.490.1,
0.400.05, p<0.05, respectively), and was further increase in T2DM pa-
tients with glucose ﬂuctuation than that in patients with non-glucose
ﬂuctuation (0.520.01 vs 0.480.11, p<0.05).
CONCLUSIONS Blood glucose variability might impair myocardial per-
formances of T2DM patients, especially for diastolic function, which con-
tributes to the risk of cardiomyopathy among diabetic individuals.
